Filters
Higher esophageal anxiety, use of adaptive behaviours, and hypervigilance are common among patients with active eosinophilic esophagitis (EoE), representing clinical markers of histological disease activity (HDA), a study has found.
Greater severity in metabolic dysfunction-associated steatotic liver disease (MASLD) may impair cognitive function and health-related quality of life (HRQoL) in patients with overweight or obesity, suggests a study.
High adiposity levels are associated with the risk of colorectal cancer (CRC), suggest the results of a systematic review. However, standardization is necessary to improve understanding of the link between CRC and adiposity to enable comparisons across papers.
Glycaemic outcomes following sleeve gastrectomy (SG) vary by race and ethnicity, with non-Hispanic Black (NHB) participants showing less favourable outcomes, reports a study.
Treatment with vedolizumab exhibits equivalent rates of response and mucosal healing but higher odds of drug persistence and achieving clinical remission compared with adalimumab in biologic-naïve patients with Crohn’s disease (CD), reports a study in a real-world setting.
Keeping a healthy lifestyle such as having a balanced diet, regular exercise, and quality sleep may provide survival benefits to patients with cirrhosis, suggests a study.
Treatment with budesonide shows better clinical remission rates and fewer adverse events (AEs) than mesalamine in patients with microscopic colitis (MC), reveals a study.
Primary sclerosing cholangitis (PSC) poses an increased risk of colorectal cancer (CRC), even in the absence of concomitant inflammatory bowel disease (IBD), according to a retrospective study.
Appendectomy does not appear to alter the clinical course of patients with ulcerative colitis (UC), such that those who undergo the procedure are not more likely to experience a milder clinical course compared with those who choose not to, regardless of underlying appendicitis, as shown in a study.
Vitamin D supplementation appears to improve inflammatory bowel disease (IBD) outcomes, including related ED visits, hospitalizations, and corticosteroid use, according to a retrospective study.